Insider Stock Trading History of Formela Jean Francois


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Formela Jean Francois since year 2005. The trader's CIK number is 1030575. At the time of this reporting, Formela Jean Francois is the Director of Spero Therapeutics, Inc. . (stock ticker symbol SPRO). See this page for all insider trading activities at Spero Therapeutics, Inc. .

Note that in the past FORMELA JEAN FRANCOIS also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Formela Jean Francois since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-06 SPRO Spero Therapeutics, Inc. Buy 428,571 14.00 5,999,994
2017-07-07 NTLA Intellia Therapeutics, Inc. Sale 30,000 16.77 502,979
2017-07-10 NTLA Intellia Therapeutics, Inc. Sale 40,000 16.17 646,880
2017-07-11 NTLA Intellia Therapeutics, Inc. Sale 80,000 16.07 1,285,600
2017-03-09 NTLA Intellia Therapeutics, Inc. Sale 15,628 13.85 216,432
2017-03-10 NTLA Intellia Therapeutics, Inc. Sale 5,504 14.06 77,408
2014-02-11 EGLT Egalet Corp Buy 41,667 12.00 500,004
2012-03-02 HZNP Horizon Pharma Plc Buy 828,443 3.62 2,999,792
2011-08-02 HZNP Horizon Pharma Plc Buy 369,814 9.00 3,328,326
2010-03-29 ABIO Nuvelo Inc Sale 140,000 7.56 1,058,400
2005-10-27 NXTM Nxstage Medical, Inc. Buy 99,923 10.00 999,230
2005-09-07 EXEL Exelixis Inc Sale 275,000 7.80 2,145,275

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Formela Jean Francois (Director of Spero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.